Biology of chronic lymphocytic leukemia
- PMID: 11491097
- DOI: 10.1046/j.1468-0734.2000.00001.x
Biology of chronic lymphocytic leukemia
Abstract
B-cell chronic lymphocytic leukemia (CLL) lies at the cross-roads of hematology, immunology and oncology for at least three major reasons: (a) it is the prototype of human malignancies that primarily involve defects in the induction of apoptosis; (b) CLL patients develop a severe immunodeficiency with progressive hypogammaglobulinemia; and (c) they have a high prevalence of autoimmune phenomena. Recent advances in the biology of the malignant cell in CLL lead to a scenario comprised of two basic elements: first, CLL cells are optimally organized to survive in their niches because their ability to undergo apoptosis is severely hampered; second, they have a microenvironment-dependence that promotes their extended survival, a situation that arises most probably through direct cell-to-cell contacts. In addition, CLL cells themselves are the major accessory cells in CLL, but are inefficient antigen-presenting cells. This latter defect may provide a clue to reinterpret the events of immunodeficiency and autoimmunity.
Similar articles
-
PD-1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Large B-cell Richter Transformation (DLBCL-RT): A Characteristic Feature of DLBCL-RT and Potential Surrogate Marker for Clonal Relatedness.Am J Surg Pathol. 2018 Jul;42(7):843-854. doi: 10.1097/PAS.0000000000001077. Am J Surg Pathol. 2018. PMID: 29762141
-
[Apoptosis in chronic lymphocytic leukemia].Medicina (B Aires). 2000;60 Suppl 2:12-6. Medicina (B Aires). 2000. PMID: 11188924 Spanish.
-
B-cell chronic lymphocytic leukemia: a bird of a different feather.J Clin Oncol. 1999 Jan;17(1):399-408. doi: 10.1200/JCO.1999.17.1.399. J Clin Oncol. 1999. PMID: 10458259 Review.
-
Signal transduction pathways and mechanisms of apoptosis in CLL B-lymphocytes: their role in CLL pathogenesis.Hematol Cell Ther. 1997 Nov;39 Suppl 1:S17-27. doi: 10.1007/s00282-997-0017-4. Hematol Cell Ther. 1997. PMID: 9471058 Review.
-
Accessory cells, cytokine loops and cell-to-cell interactions in chronic lymphocytic leukemia.Rev Clin Exp Hematol. 2000 Mar;4(1):73-98. doi: 10.1046/j.1468-0734.2000.00004.x. Rev Clin Exp Hematol. 2000. PMID: 11486331 Review.
Cited by
-
Can ex vivo evaluation (testing) predict the sensitivity of CLL cells to therapy with purine analogs in conjunction with an alkylating agent? A comparison of in vivo and ex vivo responses to treatment.Med Oncol. 2012 Sep;29(3):2111-26. doi: 10.1007/s12032-011-0105-8. Epub 2011 Nov 16. Med Oncol. 2012. PMID: 22086735
-
Extracellular vesicles and blood diseases.Int J Hematol. 2017 Apr;105(4):392-405. doi: 10.1007/s12185-017-2180-x. Epub 2017 Jan 27. Int J Hematol. 2017. PMID: 28130731 Review.
-
Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression.Blood. 2010 Mar 4;115(9):1755-64. doi: 10.1182/blood-2009-09-242719. Epub 2009 Dec 17. Blood. 2010. PMID: 20018914 Free PMC article.
-
Increased genomic alteration complexity and telomere shortening in B-CLL cells resistant to radiation-induced apoptosis.Cytogenet Genome Res. 2008;122(3-4):343-9. doi: 10.1159/000167821. Epub 2009 Jan 30. Cytogenet Genome Res. 2008. PMID: 19188704 Free PMC article.
-
The novel receptor tyrosine kinase Axl is constitutively active in B-cell chronic lymphocytic leukemia and acts as a docking site of nonreceptor kinases: implications for therapy.Blood. 2011 Feb 10;117(6):1928-37. doi: 10.1182/blood-2010-09-305649. Epub 2010 Dec 6. Blood. 2011. PMID: 21135257 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
